News

News
Partner news

Exonate Announces Collaboration with Janssen to develop a new eye drop for the treatment of retinal vascular diseases including wet age-related macular degeneration (AMD) and diabetic macular oedema (DMO)

Read full story
Partner news

Medicines Discovery Catapult, MQ: Transforming mental health and Alzheimer’s Research UK announce an innovative drug discovery consortium with industry, supported by the Wellcome Trust.

Read full story
Partner news

TU Dresden announces collaboration with Janssen to advance next-generation nuclease-free gene editing platform

Read full story
Partner news

AdoRx Therapeutics Announces Collaboration with Johnson & Johnson Innovation to Develop Novel Lung Cancer Therapeutics

Read full story
Partner news

New strategic partners join £9.5 million dementia drug discovery collaboration

Read full story
Partner news

Philogen Announces Drug Discovery Collaboration With Johnson & Johnson Innovation

Read full story
Partner news

BiomX Enters Collaboration with Johnson & Johnson Innovation for Discovery of Microbiome-based Biomarkers for IBD

Read full story
Partner news

Vect-Horus Announces Agreement With Johnson & Johnson Innovation

Read full story
Partner news

Ad Scientiam announces agreement with Johnson & Johnson Innovation to develop a digital assessment scale for Major Depressive Disorders

Read full story
Partner news

Touchlight announces collaboration with Janssen Biotech

Read full story
Partner news

BIO-Europe® Copenhagen’s Startup Slam Winner 2018: SunRegen Healthcare AG

Read full story
Partner news

Nuevolution to receive license fee payment of USD 750,000

Read full story
Partner news

Alligator Bioscience to Receive USD 6 Million Milestone Payment from Janssen Coupled to the Decision to Initiate Combination Trial with ADC-1013

Read full story